MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    The Role of Simulation-Based Learning in Enhancing Clinical Skills for Managing Parkinson’s Disease in Medical Education: A Systematic Review

    A. Elsayed, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. Alomari, M. M. Elsayed (Mansoura, Egypt)

    Objective: To evaluate the effectiveness of simulation-based learning (SBL) in enhancing clinical skills for Parkinson’s disease (PD) management among medical students and healthcare professionals. Background:…
  • 2025 International Congress

    Targeted Brain Delivery of Rifampicin via PEG-PLA Nanoparticles: A Promising Therapeutic Strategy for Neuroprotection and Disease Modification in Parkinsonian Mouse Models

    JH. Su, EX. Tao (Shenzhen, China)

    Objective: This study aimed to design and validate a nanoparticle-based delivery system for rifampicin, with the objective of enhancing its therapeutic efficacy, improving brain targeting,…
  • 2025 International Congress

    AI-Driven Wearable Sensor Monitoring for Improved Assessment of Advanced Treatment Readiness in Parkinson’s Disease – A pilot study

    N. Karottki, M. Sander, T. Hørmann Thomsen, B. Biering-Sørensen (Glostrup, Denmark)

    Objective: This study evaluated the potential of wearables and AI-driven continuous monitoring to assess motor symptoms in Parkinson’s disease (PD). We aimed to determine their…
  • 2025 International Congress

    A Systematic Review on the Reliability of Data-Driven Parkinson’s Disease Subtypes

    D. Teixeira-Dos-Santos, R. Ravazio, C. Mattjie, A. De-Oliveira-Franco, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, MA. de Bastiani, MA. Machado Schlindwein, L. Angi Souza, T. Hugentobler Schlickmann, S. Duarte Pinto, A. Bieger, R. C. Barros, E. R. Zimmer, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To systematically evaluate data-driven Parkinson’s disease (PD) subtyping studies, focusing on their methodological quality and clinical applicability. Background: The heterogeneity of PD suggests distinct…
  • 2025 International Congress

    Enhancing Safety and Quality of Care for Parkinson’s Disease Patients Hospitalized at a Large Academic Medical Center

    C. Kim, C. Malatt, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

    Objective: To implement measures to improve quality of care in Parkinson's disease (PD) patients who are hospitalized at a large academic hospital with the goal…
  • 2025 International Congress

    Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach

    L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret (London, United Kingdom)

    Objective: To describe and address sex and gender gaps in Parkinson’s disease (PD) research through a multidisciplinary, multi-stakeholder approach that includes patient representatives, researchers, clinicians,…
  • 2025 International Congress

    Gym Strength Training for People with Early Onset Parkinson’s disease

    M. Morris, C. Thwaites, D. Harris, M. Callisaya, R. Mouer, R. Blaze (Bundoora, Australia)

    Objective: For adults living with early onset Parkinson’s disease (EOPD) to evaluate the feasibility, safety and acceptability of a gym-based resistance strength training exercise program…
  • 2025 International Congress

    Effect of CUE1+ Device on Motor and Non-Motor Symptoms in Parkinson’s: A Pilot Randomised Controlled Trial.

    V. Azoidou, K. Rowsell, E. Camboe, K. Dey, A. Zirra, C. Quah, T. Boyle, C. Budu, D. Gallagher, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess the effect CUE1+ device on motor and non-motor symptoms in people with Parkinson’s (PwP). Background: Current treatments for PwP often fail to…
  • 2025 International Congress

    A Double-Blind, Cross-Over Pilot Study Comparing Adaptive Deep Brain Stimulation (aDBS) to Conventional DBS in Parkinson’s Disease

    T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)

    Objective: To compare the efficacy of adaptive deep brain stimulation (aDBS) to conventional DBS (cDBS) in Parkinson’s disease through a double-blind, cross-over pilot study. Background:…
  • 2025 International Congress

    Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of Vent-02, a Novel CNS-Penetrant NLRP3 Inhibitor for the Treatment of Parkinson’s Disease

    A. Matta, X. Valencia, L. Warner, K. Pike, C. Winters, L. Smidt, M. Moerland, O. Spiegelstein (Waltham, USA)

    Objective: The objectives of this first-in-human study were to assess the safety, tolerability, pharmacokinetics (PK), food-effect and pharmacodynamics of VENT-02 in healthy volunteers Background: Vent-02…
  • 1
  • 2
  • 3
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley